Strides Pharma Science Limited (NSE:STAR)

Strides Pharma Science Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,428	1,126	1,610	3,035	1,707	1,258
Short-Term Investments	846.14	165.59	227.8	63.63	134.55	1,490
Trading Asset Securities	-	695	1,058	508.4	-	-
Cash & Short-Term Investments	2,275	1,986	2,896	3,607	1,842	2,749
Cash Growth	-7.91%	-31.41%	-19.72%	95.84%	-32.99%	-20.88%
Accounts Receivable	11,295	12,029	11,419	12,994	12,073	11,106
Other Receivables	-	2,040	1,462	936.49	5,899	367.53
Receivables	11,438	14,174	13,008	14,008	18,020	11,514
Inventory	14,595	12,776	11,262	11,465	11,738	12,007
Prepaid Expenses	-	617.23	706.94	639.29	541.85	526.86
Other Current Assets	4,824	1,436	1,817	2,714	1,476	1,376
Total Current Assets	33,132	30,989	29,690	32,434	33,618	28,172
Property, Plant & Equipment	10,465	9,803	9,585	13,726	15,136	14,994
Long-Term Investments	3,556	3,502	2,015	4,422	5,416	6,120
Goodwill	5,687	5,466	5,294	5,138	4,859	4,805
Other Intangible Assets	6,773	5,680	5,271	5,631	6,250	6,185
Long-Term Deferred Tax Assets	2,728	2,691	2,673	2,650	2,151	1,982
Other Long-Term Assets	2,865	2,356	3,368	2,385	2,297	7,787
Total Assets	65,206	60,487	58,398	66,384	69,759	70,150
Accounts Payable	11,887	10,325	8,516	9,823	10,715	11,342
Accrued Expenses	-	1,542	1,229	1,287	1,348	1,318
Short-Term Debt	12,558	11,364	15,742	13,308	14,965	10,238
Current Portion of Long-Term Debt	-	880.06	1,689	3,039	4,598	1,970
Current Portion of Leases	349.05	325.62	307.05	514.39	465.98	345.7
Current Income Taxes Payable	875.74	340.37	404.16	267.11	238.11	351.18
Other Current Liabilities	3,234	1,139	905.91	1,664	1,786	1,819
Total Current Liabilities	28,904	25,915	28,793	29,902	34,117	27,383
Long-Term Debt	4,930	5,712	6,715	11,398	8,356	8,826
Long-Term Leases	601.08	514.58	716.35	2,037	1,865	2,103
Long-Term Unearned Revenue	-	-	-	-	-	1.08
Pension & Post-Retirement Benefits	-	602.69	548.33	408.38	450.44	404.29
Long-Term Deferred Tax Liabilities	1,417	1,194	403.45	445.71	357.19	463.48
Other Long-Term Liabilities	1,326	684.16	504.78	464.61	780.18	2,829
Total Liabilities	37,178	34,623	37,680	44,655	45,925	42,010
Common Stock	921.73	921.63	919	903.03	897.9	896.81
Additional Paid-In Capital	-	15,094	18,233	17,545	17,322	17,273
Retained Earnings	-	8,631	1,197	2,037	4,060	8,865
Comprehensive Income & Other	26,637	871.3	906.9	1,638	1,312	731.94
Total Common Equity	27,558	25,518	21,256	22,123	23,592	27,767
Minority Interest	469.1	346.33	-538.57	-393.75	240.88	373.41
Shareholders' Equity	28,028	25,865	20,717	21,729	23,833	28,140
Total Liabilities & Equity	65,206	60,487	58,398	66,384	69,759	70,150
Total Debt	18,439	18,796	25,169	30,296	30,250	23,482
Net Cash (Debt)	-16,164	-16,810	-22,273	-26,689	-28,408	-20,734
Net Cash Per Share	-175.43	-182.68	-244.75	-296.27	-316.54	-231.12
Filing Date Shares Outstanding	92.15	92.16	91.9	90.3	89.8	89.68
Total Common Shares Outstanding	92.15	92.16	91.9	90.3	89.79	89.68
Working Capital	4,228	5,074	897.42	2,532	-498.44	788.86
Book Value Per Share	299.06	276.88	231.29	244.98	262.75	309.62
Tangible Book Value	15,098	14,373	10,690	11,354	12,483	16,776
Tangible Book Value Per Share	163.85	155.95	116.33	125.73	139.03	187.06
Land	-	1,429	1,416	1,410	1,383	1,041
Buildings	-	3,413	3,225	3,844	4,205	2,857
Machinery	-	9,475	9,048	12,539	13,042	11,264
Construction In Progress	-	996.46	798.79	482.59	562.29	2,276

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.